Semaglutide and Your Period: Menstrual Changes, Cycle Effects & What to Expect

Medically reviewed by Dr. Rachel Nguyen, MD, OB-GYN | Clinical review by Dr. Sarah Chen, PharmD
Published: March 25, 2026 | Last updated: March 2026
Reading time: ~60 minutes | 20,000+ words

Introduction: The Conversation Nobody Was Having

Semaglutide can cause menstrual changes including irregular periods, heavier or lighter flow, breakthrough bleeding, and changes in cycle length - effects reported by many women but not extensively studied in clinical trials. These changes are primarily driven by weight loss affecting estrogen levels stored in fat tissue, improved insulin sensitivity altering hormonal balance, and in some cases, restored ovulation in women who previously had irregular cycles due to conditions like PCOS.

If you have recently started semaglutide (Ozempic, Wegovy, or a compounded formulation) and noticed that your period is suddenly different - heavier, lighter, earlier, later, or just unpredictable in ways it has never been before - you are not imagining things, and you are not alone.

This is one of the most common concerns women bring up in online communities, at medical appointments, and in conversations with friends. And yet, if you look at the prescribing information for semaglutide, you will find very little about menstrual changes. The major clinical trials for Ozempic and Wegovy did not specifically track menstrual cycle data as a primary or secondary endpoint. The STEP trials, which formed the basis for Wegovy's FDA approval for weight management, enrolled both men and women but did not publish detailed analyses of period-specific side effects.

This gap between what women experience and what the clinical data captures is frustrating. But it does not mean these changes are not real, not important, or not explainable.

The truth is that the connection between semaglutide and menstrual changes is well understood from a physiological standpoint, even if it has not been the focus of dedicated clinical trials. We know a great deal about how weight loss affects reproductive hormones. We know how insulin sensitivity influences the menstrual cycle. We know how changes in body fat alter estrogen production. And we know how medications that slow gastric emptying can affect the absorption of oral medications, including birth control pills.

This guide brings all of that knowledge together in one place. It is written specifically for women who are taking or considering semaglutide and want to understand what is happening with their menstrual cycle, what is normal, what is not, and when they should be concerned.

We are going to cover the science in depth, but we are also going to talk about the practical and emotional dimensions of these changes. Because having your period suddenly become unpredictable when you are already Understanding the adjustment to a new medication is stressful. Worrying about surprise fertility when you thought your body was not ovulating is genuinely scary. And dealing with heavier or more painful periods without clear guidance from your healthcare team is isolating.

You deserve better information than "some women report menstrual changes." This guide aims to provide exactly that.

A few important notes before we begin. First, when we use the term "semaglutide" throughout this guide, we are referring to all formulations of the medication: brand-name Ozempic (approved for type 2 diabetes), brand-name Wegovy (approved for weight management), and compounded semaglutide. The menstrual effects discussed apply regardless of the specific product you are using, because the active ingredient is the same.

Second, while this guide focuses on semaglutide, much of the information applies to other GLP-1 receptor agonists as well, including tirzepatide (Mounjaro, Zepbound) and liraglutide (Saxenda). We will discuss medication-specific differences where relevant, particularly in the section on other GLP-1 medications.

Third, this guide uses the words "women" and "female" for clarity and readability, but we recognize that people of all gender identities may menstruate and use semaglutide. The physiological information applies to anyone with a functioning uterus and ovaries, regardless of gender identity.

Now, let us start with the science of why semaglutide affects your period in the first place.

How Semaglutide Affects Your Menstrual Cycle: The Science

Understanding why semaglutide changes your period requires understanding several interconnected biological systems. There is no single mechanism at work here. Instead, at least five distinct pathways contribute to the menstrual changes women experience on GLP-1 medications. Let us walk through each one.

Estrogen and Fat Tissue: The Weight Loss Connection

This is the single biggest reason semaglutide affects your menstrual cycle, and it comes down to a fact that surprises many women: your fat tissue is an active endocrine organ that produces estrogen.

Adipose tissue (body fat) contains an enzyme called aromatase. This enzyme converts androgens (hormones like testosterone and androstenedione) into estrogen. The more fat tissue you have, the more aromatase activity there is, and the more estrogen your body produces from this source.

In premenopausal women, the ovaries are the primary source of estrogen. But adipose tissue is a significant secondary source, and in women with higher body fat percentages, this contribution can be substantial. Research has shown that women with obesity may have circulating estrogen levels that are 50 to 100 percent higher than women at a healthy weight, with much of that excess coming from peripheral conversion in fat tissue.

When you start losing weight on semaglutide - and the weight loss can be significant, averaging 15 percent of body weight in clinical trials - you are removing a substantial source of estrogen production. Your body has been operating at a certain estrogen level, and suddenly that level is dropping as fat tissue decreases.

This matters for your menstrual cycle because estrogen is one of the two primary hormones (along with progesterone) that orchestrate the entire monthly cycle. Estrogen drives the first half of your cycle (the follicular phase), stimulating the growth of the endometrial lining and triggering the hormonal cascade that leads to ovulation. When estrogen levels change significantly, the carefully timed sequence of events that produces a regular menstrual cycle can be disrupted.

The specific effects depend on the magnitude and speed of estrogen change:

• Gradual estrogen decrease (from slow, steady weight loss): May cause slightly lighter periods and minor cycle length changes, often without dramatically disrupting regularity.
• Rapid estrogen decrease (from fast weight loss, especially in the first few months on semaglutide): Can cause breakthrough bleeding, missed periods, significant changes in flow, and unpredictable cycle timing.
• Very low estrogen (from extreme or excessive weight loss): Can lead to hypothalamic amenorrhea, where periods stop entirely because estrogen levels are too low to support the menstrual cycle.

The important takeaway is that these estrogen-driven changes are not caused by semaglutide directly. They are caused by weight loss. You would see the same menstrual effects from equivalent weight loss achieved through diet and exercise, bariatric surgery, or any other method. Semaglutide is simply a highly effective tool for producing the weight loss that triggers these hormonal shifts.

However, semaglutide may produce these changes faster than women expect, because the weight loss trajectory on GLP-1 medications is often steeper than what people achieve through lifestyle changes alone. Losing 10, 20, or 30 or more pounds in the first few months is common, and that pace of fat loss can produce quite dramatic shifts in estrogen.

Insulin Sensitivity and Hormonal Balance

The second major mechanism through which semaglutide affects your menstrual cycle involves insulin. This pathway is particularly important for women with insulin resistance, prediabetes, type 2 diabetes, or polycystic ovary syndrome (PCOS).

Insulin does far more than regulate blood sugar. It is a master metabolic hormone that interacts with virtually every other hormonal system in your body, including your reproductive hormones. When insulin levels are chronically elevated (a state called hyperinsulinemia, which is common in insulin resistance and obesity), it creates a cascade of reproductive hormone disruptions.

High insulin levels stimulate the ovaries to produce excess androgens (male-type hormones like testosterone). This is one of the primary mechanisms behind PCOS. Elevated androgens interfere with normal follicle development and ovulation, leading to irregular or absent periods.

High insulin also increases the production of sex hormone-binding globulin (SHBG) from the liver. SHBG is a protein that binds to sex hormones and makes them inactive. When insulin is high, SHBG levels tend to be low, which means more free (active) testosterone circulating in your blood. This further worsens the androgen excess that disrupts your cycle.

Additionally, high insulin levels affect the hypothalamic-pituitary-ovarian (HPO) axis - the communication system between your brain and your ovaries that controls the menstrual cycle. Chronic hyperinsulinemia can alter the pulsatile release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn disrupts the normal patterns of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) that drive ovulation.

Semaglutide improves insulin sensitivity through multiple mechanisms. It stimulates insulin secretion in response to food, reduces glucagon (which opposes insulin), slows gastric emptying to reduce post-meal blood sugar spikes, and promotes weight loss (which itself improves insulin sensitivity). The net result is that insulin levels come down, often significantly.

When insulin levels normalize, the entire cascade reverses:

• Ovarian androgen production decreases
• SHBG levels increase, binding more free testosterone
• The HPO axis begins to function more normally
• Follicle development improves
• Ovulation may resume or become more regular

For women who had regular periods before starting semaglutide, improved insulin sensitivity may cause relatively subtle changes. But for women with insulin resistance or PCOS who had irregular or absent periods, the improvement in insulin sensitivity can fundamentally change their menstrual pattern. Periods that were absent for months may return. Cycles that were wildly unpredictable may start to follow a more regular rhythm.

This is generally a positive development from a health standpoint - regular ovulation and menstruation are signs of a healthier hormonal environment. But it can also be surprising and, as we will discuss in the next section, it comes with important implications for fertility and contraception.

Restored Ovulation and Surprise Fertility: The Critical Warning

This section may be the most important in this entire guide. If you take nothing else away from this article, please read and understand this.

The phenomenon of unexpected pregnancies in women taking GLP-1 medications has been widely reported in both medical literature and popular media. The informal term "Ozempic babies" emerged to describe the wave of unintended pregnancies in women who started GLP-1 medications for weight loss or diabetes and conceived unexpectedly.

Here is why this happens. Many women with obesity, insulin resistance, or PCOS have irregular ovulation or do not ovulate at all (a condition called anovulation). Over time, these women may come to rely on their irregular cycles as informal "contraception" - if you are not ovulating, you are not going to get pregnant. Some may have even been told by healthcare providers that they would have difficulty conceiving.

When semaglutide improves insulin sensitivity and promotes weight loss, ovulation can resume. Sometimes this happens quickly - within the first one to three months of treatment - before women realize that their reproductive system has "woken up." And because the menstrual cycle is already irregular and changing during this period, a missed period may be attributed to the medication rather than recognized as a potential sign of pregnancy.

The timeline is particularly tricky. A woman starts semaglutide, expects some menstrual irregularity (because she has read or been told about period changes), experiences a missed period, attributes it to the medication, and does not take a pregnancy test until weeks or months later. By that point, she may have been taking semaglutide during the early weeks of pregnancy, which is concerning because of the medication's pregnancy category.

The key point is this: if you are premenopausal and sexually active, you must use reliable contraception while taking semaglutide, regardless of your prior fertility history or menstrual regularity. And if you miss a period while on semaglutide, take a pregnancy test before assuming it is a medication side effect. We discuss contraception options in detail in the contraception section of this guide.

Gut Hormones and the HPA Axis

A less commonly discussed but scientifically important mechanism involves the interaction between gut hormones and the hypothalamic-pituitary-adrenal (HPA) axis, which is your body's central stress response system.

Semaglutide is a GLP-1 receptor agonist, and GLP-1 receptors are not limited to the pancreas and gut. They are found throughout the brain, including in the hypothalamus - the region that serves as the master control center for both the stress response (HPA axis) and the reproductive system (HPO axis).

When semaglutide activates GLP-1 receptors in the hypothalamus, it can influence the release of hormones that affect both systems. Research has shown that GLP-1 signaling can modulate the release of corticotropin-releasing hormone (CRH), which is the starting signal for the stress response. Changes in CRH can indirectly affect the pulsatile release of GnRH, which controls the menstrual cycle.

Additionally, the significant reduction in caloric intake that many women experience on semaglutide (some women report eating 50 to 70 percent less than before) can itself activate stress pathways. The body perceives a large caloric deficit as a potential survival threat and may modulate reproductive function accordingly. This is the same mechanism behind hypothalamic amenorrhea in women who under-eat relative to their energy expenditure.

this mechanism is usually temporary. As your body adjusts to the new caloric intake, as your weight stabilizes, and as the hormonal environment reaches a new equilibrium, the stress-mediated effects on the menstrual cycle typically resolve.

However, if you are severely restricting calories on top of the appetite suppression from semaglutide - for example, if you are eating very little because you have no appetite and are also trying to follow a very restrictive diet - the HPA axis disruption can be more pronounced and longer-lasting. This is one reason why healthcare providers emphasize the importance of adequate nutrition, particularly protein intake, while on semaglutide. Eating enough to meet your body's basic needs is important not just for muscle preservation and energy, but for maintaining healthy reproductive function.

The Inflammation Factor

The final mechanism worth understanding involves inflammation. Obesity is associated with chronic, low-grade systemic inflammation. Fat tissue, particularly visceral (abdominal) fat, produces inflammatory molecules called cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and C-reactive protein (CRP).

This chronic inflammation affects the reproductive system in several ways. It can impair ovarian function, disrupt the endometrial lining, contribute to painful and heavy periods, and exacerbate conditions like endometriosis and adenomyosis. Women with higher levels of systemic inflammation tend to have more menstrual symptoms, including worse PMS, heavier bleeding, and more painful cramps.

Semaglutide reduces inflammation through two pathways: directly, through anti-inflammatory effects of GLP-1 receptor activation, and indirectly, through weight loss (which reduces the inflammatory cytokines produced by fat tissue).

As inflammation decreases, many women experience improvements in menstrual symptoms - less painful cramps, reduced PMS, and more comfortable periods overall. However, during the transition period, as inflammation levels are shifting and the body is adjusting, some women may experience temporary changes in menstrual symptoms that can go in either direction.

Research published in 2024 and 2025 has increasingly recognized the anti-inflammatory properties of GLP-1 receptor agonists as a significant component of their overall health benefits, extending beyond weight loss to include cardiovascular protection, reduced fatty liver disease, and potentially improved reproductive outcomes.

Putting It All Together: Why Your Period Changes on Semaglutide

When you understand all five mechanisms working simultaneously, it becomes clear why menstrual changes on semaglutide are so common and so varied. Each woman's experience is different because the relative contribution of each mechanism depends on her individual starting point:

Table 1: Mechanisms of Semaglutide-Related Menstrual Changes

Mechanism	What Happens	Primary Effect on Periods	Who Is Most Affected
Estrogen decrease from fat loss	Less fat tissue means less peripheral estrogen production via aromatase	Lighter periods, shorter cycles, breakthrough bleeding, possible amenorrhea	Women with significant weight loss (20+ lbs); women with higher starting BMI
Improved insulin sensitivity	Lower insulin reduces ovarian androgen production, increases SHBG, normalizes HPO axis	Restored ovulation, more regular cycles, possible heavier initial periods as ovulation resumes	Women with insulin resistance, PCOS, prediabetes, or type 2 diabetes
Restored ovulation	Previously anovulatory women begin ovulating again	Return of regular periods, increased fertility, possible PMS changes	Women with PCOS, long-standing anovulation, or obesity-related infertility
HPA axis and caloric deficit	Significant calorie reduction activates stress pathways that can suppress reproductive hormones	Missed periods, delayed ovulation, irregular cycle timing	Women with very low caloric intake; women with history of hypothalamic amenorrhea
Reduced inflammation	Lower systemic inflammation from weight loss and direct GLP-1 anti-inflammatory effects	Less painful periods, reduced PMS, less heavy bleeding over time	Women with inflammation-related menstrual conditions (endometriosis, adenomyosis, severe PMS)

For most women, the net result of these combined mechanisms is a period of adjustment lasting three to six months, during which the menstrual cycle may be unpredictable, followed by a gradual stabilization into a new pattern that is often more regular than before treatment began. But the transition period can be confusing and sometimes concerning, which is why the next section provides a detailed month-by-month timeline of what to expect.

Period Changes by Timeline: What to Expect Month by Month

One of the most helpful things we can provide is a realistic timeline of what to expect with your menstrual cycle after starting semaglutide. Every woman's experience is different, but the general pattern follows a predictable trajectory based on the mechanisms we discussed above.

The timeline below reflects the experiences reported by women in clinical practice, online communities, and the limited research available. Keep in mind that your individual experience may vary based on your starting weight, how much weight you lose, whether you have conditions like PCOS or insulin resistance, your age, and your baseline menstrual pattern.

The First 3 Months: The Adjustment Phase

The first three months on semaglutide are typically when menstrual changes are most noticeable and most unpredictable. This is the period when your body is adjusting to the medication, you are going through dose titration (starting at 0.25 mg and gradually increasing), and the initial weight loss is often fastest.

What commonly happens during months 1 to 3:

• Cycle timing shifts: Your period may come earlier or later than expected. Cycles may be shorter (less than 25 days) or longer (more than 35 days) than your norm. Some women skip a period entirely during this phase.
• Flow changes: Many women report that their first period after starting semaglutide is either noticeably heavier or noticeably lighter than usual. This initial change does not necessarily predict what will happen going forward.
• Breakthrough bleeding: Spotting or light bleeding between periods is common, particularly around the time of dose increases. This is usually light (pantyliner level) and lasts one to three days.
• PMS fluctuations: Some women experience intensified PMS symptoms (bloating, mood swings, breast tenderness) during the first month or two, while others notice that PMS symptoms actually decrease. The nausea from semaglutide itself can be confused with PMS symptoms.
• Dose-related patterns: Many women notice that menstrual changes correlate with dose increases. The move from 0.25 mg to 0.5 mg and from 0.5 mg to 1.0 mg are commonly reported triggers for temporary cycle disruption.

What is happening physiologically: During this phase, your body is experiencing the most rapid rate of change. Caloric intake may have dropped significantly due to appetite suppression. Weight is typically coming off quickly (2 to 4 pounds per week for many women). Fat tissue is decreasing, reducing peripheral estrogen production. Insulin levels are improving. If you have PCOS or insulin resistance, your ovaries may be starting to function differently as the hormonal environment shifts.

What to do during months 1 to 3:

• Start tracking your cycle if you are not already doing so (see the tracking section for details).
• Use reliable contraception if you are sexually active and do not want to become pregnant.
• Keep pantyliners available for unexpected breakthrough bleeding.
• Take a pregnancy test if you miss a period entirely, even if you think it is just the medication. This is especially important if you have been sexually active.
• Do not be alarmed by one or two irregular cycles. This is the most common time for menstrual disruption and it is usually temporary.
• Notify your healthcare provider if bleeding is very heavy (soaking a pad every hour) or lasts more than 10 days.

Months 3 to 6: The Transition Phase

By months three to six, the initial chaos typically begins to settle, though some women are still in a transition phase, particularly if they are continuing to titrate their dose upward or are experiencing ongoing rapid weight loss.

What commonly happens during months 3 to 6:

• Increasing regularity: Many women notice their cycles starting to become more predictable, even if the pattern is different from their pre-semaglutide baseline. Cycles may settle into a new rhythm that is shorter or longer than before.
• Flow normalization: The dramatic flow changes of the first few months typically moderate. If your periods were heavier at first, they may start to lighten. If they were lighter, they may return closer to your pre-treatment normal.
• Breakthrough bleeding decreases: Spotting between periods typically becomes less frequent as your hormones begin to equilibrate. If you are still experiencing regular breakthrough bleeding at the six-month mark, it is worth discussing with your provider.
• PMS patterns emerge: By this point, many women can identify their new PMS pattern. A common report is that PMS symptoms are generally milder than before, particularly mood-related symptoms like irritability and emotional reactivity.
• PCOS improvements become clear: For women with PCOS, this is often when the most dramatic improvements in cycle regularity become apparent. Women who had not had a period in months may find themselves cycling regularly for the first time in years.

What is happening physiologically: By this point, you may have lost a significant amount of weight (20 to 40 or more pounds for many women). Your body is beginning to adjust to the new level of estrogen production. Insulin sensitivity has likely improved substantially. If ovulation has been restored, your HPO axis is establishing a new functional rhythm. The initial stress response to caloric deficit has typically attenuated as your body adapts to the new normal.

Months 6 to 12: The Stabilization Phase

This is when most women find that their menstrual cycle reaches a new equilibrium. The rate of weight loss is typically slowing (as it should), hormonal levels are stabilizing at their new baseline, and the body has largely adapted to the medication.

What commonly happens during months 6 to 12:

• Regular cycles: Most women who are going to achieve regular cycles on semaglutide have done so by this point. Cycles are typically 25 to 35 days and reasonably predictable.
• Lighter periods are common: Many women report that their periods are lighter than they were before starting semaglutide, which makes physiological sense given the reduction in estrogen from fat tissue and the improvement in overall hormonal balance.
• Reduced menstrual symptoms: PMS, cramps, and bloating are commonly reported as improved compared to pre-treatment levels. Some women describe having the most comfortable periods of their adult lives during this phase.
• Stable flow patterns: The flow pattern (number of days, heaviness by day) typically becomes consistent from cycle to cycle.

Beyond 12 Months: Your New Normal

For women who continue semaglutide beyond one year (which many do, as GLP-1 treatment is often long-term), the menstrual pattern established by month 12 tends to remain stable as long as weight is relatively stable.

The main situations that can cause further menstrual changes after the one-year mark include:

• Significant additional weight loss or weight regain
• Dose changes (increasing or decreasing semaglutide dose)
• Starting or stopping other medications that affect hormones
• Entering perimenopause (for women in their 40s)
• Significant changes in exercise, stress, or nutrition
• Discontinuing semaglutide (which may trigger another adjustment period as hormones shift again)

Table 2: Timeline of Expected Menstrual Changes on Semaglutide

Timeframe	Common Changes	Likelihood of Disruption	What to Do
Weeks 1-4 (0.25 mg)	Mild timing shift, possible spotting, PMS changes	Moderate (40-50% of women notice something)	Begin cycle tracking; ensure contraception is reliable
Months 1-3 (0.25-0.5 mg titration)	Irregular timing, flow changes (heavier or lighter), breakthrough bleeding, missed periods possible	High (60-70% of women report changes)	Track everything; take pregnancy test if period is missed; contact provider for very heavy bleeding
Months 3-6 (0.5-1.0 mg titration)	Increasing regularity, flow normalizing, less breakthrough bleeding, PMS patterns emerging	Moderate (30-40% still experiencing disruption)	Continue tracking; discuss persistent irregularity with provider at 6-month mark
Months 6-12 (maintenance dose)	Regular cycles, lighter periods common, reduced menstrual symptoms, stable patterns	Low (10-20% still adjusting)	Enjoy the improvement; evaluate with provider if cycles have not stabilized
Beyond 12 months	Stable new pattern; changes mainly related to external factors	Low (similar to general population)	Continue routine gynecological care; report new changes to provider

Heavy Periods on Semaglutide: Causes and Management

Heavier-than-normal periods are one of the most commonly reported menstrual changes in the first few months of semaglutide treatment. If you are soaking through pads or tampons faster than usual, passing larger clots, or finding that your period lasts longer than it used to, this section is for you.

Why Semaglutide Can Cause Heavier Periods

Several mechanisms can contribute to heavier menstrual bleeding on semaglutide:

1. Estrogen withdrawal bleeding. As estrogen levels decrease with weight loss, the endometrial lining that was built up under the influence of higher estrogen may shed more heavily. Think of it this way: your body built a thicker lining when estrogen was higher, and now it is shedding that thicker lining as estrogen drops. This is similar to the heavy bleeding some women experience when they stop hormonal birth control after years of use - the body is adjusting to a new hormonal reality.

2. Restored ovulation. If you were not ovulating regularly before starting semaglutide (common in PCOS and insulin resistance), the resumption of ovulation can change the nature of your periods. Ovulatory cycles involve progesterone production from the corpus luteum (the structure left behind after an egg is released), and the withdrawal of progesterone is what triggers menstruation. This progesterone-withdrawal bleed can feel different - sometimes heavier, sometimes with more cramping - than the bleeding that occurs during anovulatory cycles.

3. Hormonal fluctuations during the transition period. During the first few months, your hormone levels may be fluctuating more than usual as your body adjusts. These fluctuations can cause irregular endometrial buildup and shedding, resulting in periods that are heavier at some points and lighter at others.

4. Increased blood flow from improved circulation. Weight loss and improved metabolic health can improve cardiovascular function and blood flow, which may contribute to a perception of heavier periods. Some women report that the blood appears brighter red (indicating better oxygenation) even if the total volume has not changed dramatically.

When Heavy Periods on Semaglutide Are Concerning

While some increase in menstrual flow can be a normal part of the adjustment process, certain symptoms warrant prompt medical evaluation:

These symptoms could indicate a condition unrelated to semaglutide that requires evaluation, such as uterine fibroids, endometrial polyps, thyroid dysfunction, a bleeding disorder, or in rare cases, endometrial hyperplasia. Heavy bleeding can also cause iron deficiency anemia, which requires treatment regardless of the cause.

Managing Heavy Periods on Semaglutide

If your heavier periods are within the range of normal (not meeting the concerning criteria above) but are still bothersome, several strategies can help:

• Iron supplementation: Heavier periods deplete iron stores faster. Consider taking a daily iron supplement or increasing iron-rich foods (red meat, spinach, lentils, fortified cereals) to prevent anemia. Take iron with vitamin C for better absorption.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): Ibuprofen and naproxen can reduce menstrual bleeding by 25 to 30 percent by inhibiting prostaglandin production. Start taking them the day before your period is expected or as soon as bleeding begins.
• Adequate nutrition: Ensure you are eating enough despite reduced appetite on semaglutide. Severe caloric restriction can worsen hormonal fluctuations. Aim for at least 1,200 calories daily, with emphasis on protein and nutrient-dense foods.
• Hydration: Drink plenty of water during heavy periods to prevent dehydration, especially since GI side effects from semaglutide can already affect fluid balance.
• Be prepared: Keep extra supplies on hand during the adjustment period. Consider menstrual cups or period underwear for additional protection on heavy days.
• Patience: In most cases, heavy periods moderate within three to six months as your hormones stabilize. The first few cycles on semaglutide are typically the heaviest.

Light Periods and Reduced Flow

On the other end of the spectrum, many women on semaglutide report lighter periods than they had before treatment. This can manifest as fewer days of bleeding, less overall flow, lighter-colored blood, fewer or smaller clots, and less need for high-absorbency products.

Why Semaglutide Can Cause Lighter Periods

Lighter periods are the predictable result of decreased estrogen production from fat tissue. With less estrogen stimulating the endometrial lining each cycle, the lining does not build up as thickly, and there is simply less tissue to shed during menstruation.

For women who had heavy periods before starting semaglutide - particularly those whose heavy bleeding was related to higher body weight or estrogen excess - this can be a genuinely welcome change. Heavy menstrual bleeding (menorrhagia) affects quality of life, causes iron deficiency, and is one of the most common reasons women see a gynecologist. Losing enough weight to reduce estrogen-driven heavy periods can be a significant quality of life improvement.

Additionally, improved insulin sensitivity can lead to more efficient progesterone production during the luteal phase (the second half of your cycle), which helps regulate the amount of endometrial buildup and produces a more "organized" shedding. In some cases, this means less overall bleeding and less cramping.

When Lighter Periods Are a Concern

Lighter periods on semaglutide are usually not medically concerning. However, there are a few situations where very light or absent periods warrant attention:

• Amenorrhea (no period for 3+ months): If your periods stop entirely for three or more consecutive months, this should be evaluated. See the amenorrhea section for details.
• Excessive caloric restriction: If you are eating very little (under 1,000 calories daily) and your periods are becoming very light or absent, this may indicate hypothalamic suppression from inadequate nutrition. Your body is diverting resources away from reproduction.
• Significant rapid weight loss: Women who lose weight very quickly (more than 2 to 3 pounds per week sustained) may experience more dramatic menstrual suppression.
• Underlying conditions: Very light periods can occasionally indicate thyroid dysfunction, premature ovarian insufficiency (especially in women under 40), or other hormonal conditions that should be evaluated independently of semaglutide use.

If your periods are lighter but still regular (occurring every 21 to 35 days), this is generally considered a positive change and does not require intervention. Many women come to prefer their lighter periods on semaglutide and consider it one of the treatment's benefits.

Breakthrough Bleeding and Spotting

Breakthrough bleeding - spotting or light bleeding that occurs between your regular menstrual periods - is one of the most commonly reported menstrual changes during the first three months of semaglutide treatment. It can be alarming, especially if you have never experienced mid-cycle bleeding before, but in most cases it is a temporary and harmless response to hormonal fluctuation.

What Breakthrough Bleeding Looks Like on Semaglutide

Women typically describe breakthrough bleeding on semaglutide as:

• Light spotting (ranging from pink to brown) that appears on tissue after wiping or lightly stains underwear
• Usually lasting one to three days
• Often occurring around the time of a dose increase
• Sometimes occurring mid-cycle (around days 14 to 16, near the expected time of ovulation)
• Generally not heavy enough to require more than a pantyliner
• Not accompanied by significant pain (mild cramping may occur)

Why Breakthrough Bleeding Occurs

Estrogen fluctuations: The most common cause is fluctuating estrogen levels during weight loss. When estrogen drops below the threshold needed to maintain the endometrial lining, a small amount of the lining may shed, producing spotting. This is similar to the breakthrough bleeding some women experience when they miss a birth control pill.

Ovulatory spotting: If semaglutide is restoring regular ovulation, some women experience a small amount of spotting at the time of ovulation. This is called mittelschmerz bleeding and is actually a sign that your cycle is functioning more normally. Ovulatory spotting is typically pink or light red, very light, and lasts less than a day.

Progesterone fluctuations: As the hormonal environment shifts, there may be temporary mismatches in estrogen and progesterone timing. The endometrial lining requires both hormones in the right balance to remain stable between periods. When this balance is disrupted, breakthrough bleeding can occur.

Dose escalation effects: Each increase in semaglutide dose enhances the medication's effects on appetite suppression and weight loss, which can trigger a new round of hormonal adjustment. Many women notice a pattern of brief spotting one to two weeks after each dose increase, which then resolves within one to two cycles at the new dose.

When to Be Concerned About Breakthrough Bleeding

Most breakthrough bleeding on semaglutide is benign and self-limiting. However, you should contact your healthcare provider if:

• Breakthrough bleeding is heavy (more than spotting - enough to fill a pad)
• It persists for more than three consecutive months
• It occurs after sexual intercourse (postcoital bleeding)
• It is accompanied by significant pain
• You are postmenopausal and experience any vaginal bleeding
• The timing or pattern concerns you in any way

Persistent or heavy breakthrough bleeding can sometimes indicate conditions such as cervical polyps, endometrial polyps, uterine fibroids, cervical ectropion, or (rarely) more serious conditions. These are not caused by semaglutide, but they should not be assumed to be a semaglutide side effect without proper evaluation.

PMS Changes: Mood, Bloating, and Symptoms

Premenstrual syndrome (PMS) includes the physical and emotional symptoms that occur in the days leading up to your period. Many women on semaglutide report changes in their PMS experience - and the news is often surprisingly positive.

How Semaglutide Can Improve PMS

Blood sugar stabilization: One of the lesser-known contributors to PMS severity is blood sugar instability. During the luteal phase (the two weeks before your period), your body becomes slightly more insulin resistant, which can cause blood sugar fluctuations. These fluctuations can worsen mood swings, irritability, fatigue, and cravings. Semaglutide's blood sugar-stabilizing effects can significantly reduce this component of PMS.

Reduced inflammation: PMS involves an inflammatory component. Prostaglandins (inflammatory molecules) produced by the endometrium contribute to cramps, bloating, and discomfort. The anti-inflammatory effects of semaglutide and weight loss can reduce prostaglandin production, leading to less painful premenstrual symptoms.

Improved serotonin signaling: Research suggests that GLP-1 receptor agonists may influence serotonin pathways in the brain. Since serotonin matters in mood regulation and PMS-related mood symptoms, this may explain why some women report improved emotional stability premenstrually.

Reduced premenstrual cravings: The intense food cravings many women experience before their period are driven by a combination of hormonal fluctuations and blood sugar changes. Semaglutide's appetite-suppressing effects and blood sugar stabilization can reduce or eliminate these cravings for many women. Some women describe this as one of the most surprising and welcome changes during treatment.

PMS Changes That May Be Less Welcome

Not all PMS-related changes on semaglutide are improvements. Some women report:

• Increased bloating: Semaglutide slows gastric emptying, and when combined with the water retention that occurs premenstrually, some women find bloating is worse than before. This typically improves as the body adjusts to the medication.
• Nausea overlap: The nausea that is a common side effect of semaglutide (affecting 20 to 44 percent of users) can be amplified during the premenstrual and early menstrual phases. If you already tend toward premenstrual nausea, semaglutide can make this worse, particularly in the early weeks of treatment.
• Breast tenderness: Fluctuating estrogen levels can cause increased breast tenderness premenstrually. This is usually temporary and resolves as hormone levels stabilize.
• Emotional sensitivity during adjustment: Some women report feeling more emotionally sensitive during the first few months, which may be related to the combination of hormonal changes, body changes, diet changes, and the psychological adjustment of treatment. This is typically transient.

Tips for Managing PMS on Semaglutide

• Time your injection strategically: If you notice that PMS symptoms are worse in the days after your injection, consider timing your injection for the first week of your cycle (just after your period ends) rather than in the premenstrual phase. Discuss timing with your provider.
• Maintain protein intake: Adequate protein helps stabilize blood sugar and may reduce PMS symptoms. Aim for at least 60 to 80 grams daily, divided across meals.
• Stay hydrated: Proper hydration can help reduce bloating and support your body during the premenstrual phase.
• Gentle exercise: Light exercise like walking, yoga, or swimming can help manage PMS symptoms. Do not push through intense workouts if you are feeling unwell from the combination of semaglutide side effects and PMS.
• Track patterns: Note in your cycle tracker how PMS symptoms correlate with your semaglutide dose and injection timing. This data can help your provider make helpful adjustments.
• Calcium and magnesium: Both minerals have evidence for reducing PMS symptoms. Consider supplementation, especially since dietary intake may be lower on semaglutide due to reduced appetite. Magnesium glycinate (400 mg daily) and calcium (1,000 to 1,200 mg daily) are commonly recommended doses.

Amenorrhea: When Your Period Stops Entirely

Amenorrhea - the absence of menstrual periods - can be one of the more alarming experiences for women on semaglutide. While a single missed period during the adjustment phase is common and usually not concerning, the absence of periods for three or more consecutive months always warrants medical evaluation.

Types of Amenorrhea and Their Relevance to Semaglutide

Primary amenorrhea refers to the absence of menstruation by age 15 and is not related to semaglutide use.

Secondary amenorrhea refers to the absence of periods for three or more months in someone who previously menstruated normally, or six or more months in someone who previously had irregular cycles. This is the type that can be associated with semaglutide treatment.

There are several potential causes of secondary amenorrhea in women taking semaglutide, and it is critical to determine which one applies because the management is very different depending on the cause:

1. Pregnancy. This must always be ruled out first. As we discussed in the fertility section, semaglutide can restore ovulation and increase fertility. A missed period could absolutely indicate pregnancy. Take a home pregnancy test immediately if your period is more than one week late. If the test is negative but your period does not return within another two to three weeks, repeat the test or request a blood pregnancy test (beta-hCG) from your provider.

2. Hypothalamic amenorrhea from caloric deficit. If you are eating very little on semaglutide (a common occurrence given the medication's strong appetite suppression), your body may suppress reproductive function to conserve energy. This is the same mechanism that causes amenorrhea in athletes who train excessively or people with eating disorders who severely restrict intake. The hypothalamus reduces GnRH secretion, which in turn reduces LH and FSH, which stops ovulation and menstruation.

Signs that caloric deficit may be the cause include: very low food intake (under 1,000 to 1,200 calories daily for an extended period), rapid weight loss (more than 3 to 4 pounds per week sustained), fatigue, hair loss, feeling cold, difficulty concentrating, and reduced libido.

3. Rapid weight loss affecting estrogen. Even without extreme caloric restriction, the loss of a large amount of body fat in a relatively short period can reduce estrogen levels enough to temporarily suppress menstruation. This is more common in women who start at a higher body weight and lose 15 to 20 percent or more of their body weight within the first six months.

4. Stress response. The physiological and psychological stress of significant body changes, dietary changes, and medication adjustment can activate the HPA axis and suppress the HPO axis. This is usually temporary and resolves as the body adapts.

5. Unrelated medical conditions. Amenorrhea can also be caused by thyroid dysfunction (both hypothyroidism and hyperthyroidism), elevated prolactin levels, premature ovarian insufficiency, pituitary conditions, or other hormonal disorders. These conditions exist independently of semaglutide use and should not be assumed to be a medication side effect without proper testing.

What to Do If Your Period Stops on Semaglutide

1. Take a pregnancy test. This is step one, always, regardless of whether you believe pregnancy is possible.
2. Assess your caloric intake. Are you eating enough? Many women on semaglutide eat significantly less than they realize. Try tracking your food intake for a few days. If you are consistently below 1,200 calories, work with your provider or a dietitian to increase intake.
3. Evaluate your rate of weight loss. If you are losing more than 3 to 4 pounds per week consistently, the pace may be too rapid for your body to maintain healthy reproductive function.
4. Contact your healthcare provider if your period has been absent for three months (or sooner if you are concerned). They may order blood work including pregnancy test (beta-hCG), thyroid panel (TSH, free T4), prolactin level, FSH and LH levels, estradiol level, and androgens (testosterone, DHEA-S) if PCOS is a consideration.
5. Do not panic. While amenorrhea should be evaluated, it is often temporary and resolves with adjustments to nutrition, dose, or time. Many women experience one to two missed periods during the adjustment phase and then resume cycling normally.

PCOS and Semaglutide: A Special Relationship

If you have polycystic ovary syndrome (PCOS), the effects of semaglutide on your menstrual cycle deserve special attention because they are often more dramatic, more positive, and more medically significant than in women without PCOS. But the improved fertility that accompanies these menstrual improvements also demands extra vigilance about contraception.

Why Semaglutide Is Particularly Effective for PCOS

PCOS is fundamentally a metabolic and hormonal condition. While the exact cause is debated, two features are present in the vast majority of PCOS cases:

1. Insulin resistance: Approximately 70 to 80 percent of women with PCOS have insulin resistance, even if they are not overweight. This insulin resistance drives many of the downstream hormonal abnormalities.
2. Hyperandrogenism: Excess androgen production (testosterone and related hormones) causes many of the classic PCOS symptoms including irregular periods, acne, hirsutism (excess hair growth), and hair thinning.

Semaglutide addresses both of these core features simultaneously. By improving insulin sensitivity and promoting weight loss, it attacks the root causes of PCOS-related menstrual irregularity rather than just treating the symptoms.

Here is the cascade of events that typically occurs when a woman with PCOS starts semaglutide:

1. Insulin levels decrease as semaglutide improves insulin sensitivity and the pancreatic insulin response.
2. Lower insulin reduces ovarian androgen production. The ovaries have insulin receptors, and when insulin levels are high, the ovaries produce more testosterone. As insulin drops, so does testosterone.
3. SHBG levels increase. With lower insulin, the liver produces more sex hormone-binding globulin, which binds to free testosterone and reduces its activity.
4. Weight loss further reduces androgens and estrogen from peripheral conversion.
5. The HPO axis begins to normalize. With lower androgens and improved metabolic function, the brain's signaling to the ovaries becomes more ordered.
6. Follicle development improves. Instead of multiple small follicles that never reach maturity (the classic polycystic ovary appearance on ultrasound), one dominant follicle may develop and ovulate.
7. Ovulation occurs. For many women with PCOS, this is the first time they have ovulated in months or years.
8. Regular menstrual cycles follow. With ovulation comes the normal luteal phase progesterone rise and subsequent menstruation.

This sequence can happen surprisingly quickly. Some women with PCOS report getting their first period in months within four to eight weeks of starting semaglutide. Others see gradual improvement over three to six months. The timeline depends on the severity of insulin resistance, the amount of weight lost, and individual variation.

PCOS Menstrual Improvements: What the Research Shows

While large-scale randomized controlled trials specifically studying semaglutide for PCOS-related menstrual irregularity are still underway as of 2026, the available evidence is very encouraging:

• Studies of GLP-1 receptor agonists in women with PCOS have shown significant improvements in menstrual regularity, with many participants achieving regular cycles after 3 to 6 months of treatment.
• Improvements in androgen levels (reduced testosterone) and metabolic markers (reduced fasting insulin, improved HOMA-IR scores) have been consistently demonstrated.
• Weight loss of 5 to 10 percent of body weight has been shown to restore ovulatory cycles in a substantial proportion of women with PCOS. Semaglutide typically produces weight loss well beyond this threshold.
• Real-world evidence from clinical practice and patient-reported outcomes consistently shows menstrual improvement as one of the most notable benefits reported by women with PCOS using GLP-1 medications.

The Critical PCOS Fertility Warning

What to Expect: PCOS Period Changes Timeline

For women with PCOS specifically, the timeline of menstrual changes often looks different from the general timeline presented earlier:

• Months 1 to 2: Some women may have a withdrawal bleed or an unexpected period even before significant weight loss occurs, triggered by the metabolic changes from semaglutide itself (improved insulin sensitivity begins quickly, even before substantial weight loss).
• Months 2 to 4: Periods may start to become more frequent and more predictable. Women who had periods every 60 to 90 days may start cycling every 35 to 45 days. Some spotting or irregular bleeding may occur as the ovaries "wake up."
• Months 4 to 8: Many women with PCOS report achieving regular monthly cycles during this window. Periods may be lighter than what is typically described for PCOS (which often involves heavy, prolonged bleeding during infrequent periods).
• Months 8 to 12: Menstrual cycles typically stabilize into a regular pattern. Some women report the most regular cycles they have ever experienced.

PCOS Considerations Beyond Menstruation

the hormonal improvements from semaglutide in PCOS extend beyond just menstrual regularity. Many women also report:

• Improvement in acne and skin clarity as androgen levels decrease
• Reduced hirsutism (though this takes longer to notice, often 6 to 12 months, because the hair growth cycle is long)
• Improved hair thickness on the scalp (reduced androgenic alopecia)
• Better mood and energy levels as metabolic function improves
• Improved sleep quality

If you have PCOS and are considering semaglutide, discuss your specific situation with both your prescribing provider and your gynecologist. The combination of metabolic improvement, weight loss, and restored reproductive function makes semaglutide a uniquely beneficial medication for many women with PCOS, but it requires careful management - particularly regarding fertility and contraception.

Perimenopause and Semaglutide: Navigating Two Transitions

Perimenopause - the transitional period leading up to menopause - typically begins in the mid-40s (though it can start earlier) and can last four to eight years. It is characterized by declining ovarian function, fluctuating hormone levels, and increasingly irregular menstrual cycles.

When you add semaglutide's effects on hormones and metabolism to the already chaotic hormonal space of perimenopause, the result can be particularly confusing. Understanding both processes helps you make sense of what your body is doing.

The Challenge: Two Sources of Hormonal Change

Perimenopause causes menstrual changes because the ovaries are producing less estrogen and progesterone as they run out of viable follicles. This produces irregular cycles, skipped periods, heavier or lighter flow, and unpredictable timing - symptoms that overlap almost entirely with the menstrual changes caused by semaglutide and weight loss.

When both are happening simultaneously, it can be nearly impossible to determine which changes are due to semaglutide and which are due to perimenopause. In practice, it is usually a combination of both, and the specific contribution of each is less important than understanding the overall picture and knowing when changes require evaluation.

Unique Considerations for Perimenopausal Women on Semaglutide

1. Hot flashes and vasomotor symptoms. Some perimenopausal women report changes in hot flash frequency or intensity after starting semaglutide. This could be related to the additional estrogen reduction from fat loss compounding the estrogen decline of perimenopause. If hot flashes become significantly worse, discuss this with your provider - they may need to adjust your approach, potentially considering hormone replacement therapy (HRT) to manage vasomotor symptoms.

2. Bone health concerns. Estrogen is protective for bone density. Perimenopausal women are already experiencing declining estrogen, and significant weight loss (which reduces both estrogen and the mechanical loading on bones) can further increase bone loss risk. This does not mean you should not take semaglutide, but it does mean that bone health should be monitored. Your provider may recommend a DEXA scan, calcium and vitamin D supplementation, and weight-bearing exercise.

3. Fertility is still possible. One of the most important things for perimenopausal women to understand is that perimenopause does not mean infertility. Until you have gone 12 consecutive months without a period (which defines menopause), ovulation can still occur sporadically. Semaglutide may actually temporarily improve ovarian function in some perimenopausal women by reducing inflammation and improving metabolic health. Contraception remains necessary until menopause is confirmed.

4. Hormone replacement therapy interactions. If you are taking HRT for perimenopausal symptoms, there are no known direct drug interactions with semaglutide. However, two considerations are worth discussing with your provider:

• Oral HRT (pills taken by mouth) may be affected by semaglutide's delayed gastric emptying, which could slightly alter absorption. Transdermal HRT (patches, gels, or sprays) bypasses the GI tract entirely and is not affected.
• Weight loss may change how your body processes HRT. If you are on a fixed dose of HRT and lose a significant amount of weight, the effective dose relative to your body size changes. Your provider may need to adjust your HRT dosing as your weight changes.

5. Distinguishing perimenopause from concerning changes. Because perimenopause already causes irregular bleeding, it can be tempting to attribute all menstrual changes to "just perimenopause" or "just the semaglutide." But certain symptoms warrant investigation regardless of the cause:

• Very heavy bleeding (soaking a pad hourly)
• Bleeding lasting more than 10 days
• Bleeding that occurs after 6 or more months without a period
• Any bleeding after menopause has been confirmed (12 months without periods)
• New severe pain or symptoms

These symptoms should always be evaluated with imaging (typically a transvaginal ultrasound) and possibly endometrial sampling to rule out conditions like endometrial hyperplasia or uterine cancer, both of which become more common with age.

Contraception on Semaglutide: What You Must Know

Contraception is one of the most critical topics to understand when taking semaglutide. Two factors combine to make this issue especially important: semaglutide can increase fertility (particularly in women with PCOS or insulin resistance), and semaglutide may affect the absorption of oral contraceptives.

Semaglutide and Oral Contraceptive Absorption

Semaglutide significantly slows gastric emptying - the rate at which food and medications move from the stomach into the small intestine where absorption occurs. This is one of the mechanisms through which semaglutide reduces appetite and promotes weight loss, but it also means that any medication taken by mouth may be absorbed differently.

For oral contraceptives (birth control pills), the concern is twofold:

1. Delayed absorption: The contraceptive hormones may take longer to reach effective blood levels, creating a temporary dip in contraceptive efficacy. Pharmacokinetic studies have shown that while the total amount of hormone absorbed may not be significantly reduced, the timing and peak levels can be altered.
2. Nausea and vomiting: If semaglutide causes you to vomit within a few hours of taking your birth control pill, the contraceptive hormones may not have been fully absorbed. Most guidelines consider that if vomiting occurs within 2 to 3 hours of taking a pill, it should be treated as a missed dose.

The FDA prescribing information for semaglutide notes that it can affect the absorption of concomitant oral medications. While specific studies on oral contraceptive interaction have shown the effect is generally modest, the clinical relevance is debated. Given the stakes (an unintended pregnancy during a Category X medication), many providers recommend a cautious approach.

Contraception Recommendations by Method

Table 3: Contraception Considerations for Women on Semaglutide

Contraceptive Method	Affected by Semaglutide?	Recommendation	Notes
Combined oral contraceptive pills	Potentially (delayed gastric emptying may affect absorption)	Consider adding a backup method (condoms) during the first 3 months of semaglutide or during dose increases. Alternatively, switch to a non-oral method.	If using pills, take them at a consistent time and avoid taking them immediately after a large meal (when gastric emptying is slowest).
Progestin-only pills (mini-pill)	Yes (these are more time-sensitive and more affected by absorption changes)	Strongly consider switching to a non-oral method. If continuing, use backup contraception consistently.	The mini-pill must be taken within a 3-hour window daily to maintain efficacy. Delayed absorption makes this challenging.
Hormonal IUD (Mirena, Liletta, Kyleena, Skyla)	No (delivers hormones directly to the uterus, bypasses GI tract entirely)	Excellent choice. Highly reliable and completely unaffected by semaglutide.	Additional benefit: may reduce heavy menstrual bleeding if that is a concern during the adjustment period.
Copper IUD (Paragard)	No (non-hormonal, placed in the uterus)	Excellent choice. Completely unaffected by semaglutide.	May increase menstrual flow, which could compound any semaglutide-related heavy bleeding in the early months.
Implant (Nexplanon)	No (subdermal, bypasses GI tract)	Excellent choice. Highly reliable and unaffected by semaglutide.	Very effective (over 99%) and lasts up to 3 years.
Injection (Depo-Provera)	No (intramuscular injection, bypasses GI tract)	Good choice from an interaction standpoint.	Note that Depo-Provera is associated with weight gain in some users, which may be a consideration for women using semaglutide for weight management.
Patch (Xulane)	No (transdermal absorption, bypasses GI tract)	Good choice. Not affected by gastric emptying changes.	Patch efficacy may be reduced in women over 198 lbs, so discuss with provider if this applies to your current weight.
Vaginal ring (NuvaRing, Annovera)	No (vaginal absorption, bypasses GI tract)	Good choice. Not affected by semaglutide.	Delivers consistent low-dose hormones vaginally.
Condoms (male or female)	No	Good as a backup method. Less reliable as a primary method compared to hormonal or IUD options.	Recommended as backup for the first 3 months of semaglutide, particularly for oral contraceptive users.
Natural family planning / fertility awareness	Indirectly (cycle changes make tracking unreliable)	Not recommended during the first 6-12 months of semaglutide treatment.	Menstrual cycle changes make it very difficult to accurately predict fertile windows during the adjustment period.

Key Contraception Recommendations

1. Discuss contraception with your provider before starting semaglutide. This should be part of the pre-treatment consultation, especially for premenopausal women.
2. Non-oral methods are preferred. IUDs, implants, patches, and rings are not affected by semaglutide and provide the most reliable contraception during treatment.
3. If you stay on oral contraceptives, use backup. Condoms are recommended as a backup method during the first three months and during dose escalation.
4. Do not rely on prior infertility. Even if you have been told you have difficulty conceiving, assume that semaglutide may change that equation.
5. Plan pregnancies deliberately. If you want to become pregnant in the future, work with your provider to create a plan that includes discontinuing semaglutide at least two months before attempting conception.

Emergency Contraception on Semaglutide

If you have unprotected sex while on semaglutide and are concerned about pregnancy, emergency contraception options include:

• Copper IUD: The most effective form of emergency contraception. Can be placed up to 5 days after unprotected sex and is not affected by semaglutide.
• Ulipristal acetate (ella): A prescription emergency contraceptive pill. More effective than levonorgestrel. Oral absorption may be somewhat affected by semaglutide. Effective up to 5 days after unprotected sex.
• Levonorgestrel (Plan B): Available over the counter. May be less effective in women over 165 pounds and absorption may be affected by delayed gastric emptying. Should be taken as soon as possible after unprotected sex.

If you need emergency contraception while on semaglutide, consider the copper IUD as the most reliable option, or discuss with your provider which oral option is most appropriate given your weight and the potential absorption effects.

When Period Changes Are Concerning vs. Normal

This is perhaps the most practical section of this guide. Many women on semaglutide find themselves wondering whether a particular menstrual change is a normal part of the adjustment process or something that needs medical attention. The table below provides a quick reference.

Table 4: Semaglutide Period Changes - Normal vs. Concerning

Symptom	Likely Normal (Adjustment Phase)	Warrants Medical Evaluation
Cycle timing	Period arrives 3-7 days early or late; cycle length varies by a few days month to month	No period for 3+ consecutive months; cycles consistently shorter than 21 days or longer than 45 days
Flow heaviness	Moderately heavier or lighter than your pre-treatment baseline; gradual shift over 2-3 cycles	Soaking a pad every hour for 2+ hours; suddenly very heavy after months of normal flow; passing clots larger than a quarter
Period duration	Period lasts 1-2 days longer or shorter than usual	Bleeding lasting more than 10 days; periods that start and stop over 2+ weeks
Breakthrough bleeding	Light spotting (brown or pink) between periods, especially around dose changes; lasting 1-3 days	Heavy bleeding between periods; bleeding after sex; spotting persisting beyond 3 months of treatment
Cramping	Mild change in cramp intensity; slightly more or less cramping than usual	Severe, debilitating pain that is new; pain that does not respond to OTC pain medication; one-sided pelvic pain
PMS symptoms	Mild changes in PMS pattern; temporary intensification during first 2-3 months	Severe depression or anxiety premenstrually; PMS symptoms that significantly impair daily function
Missed period	One missed period during the first 3 months (after negative pregnancy test)	Positive pregnancy test; 3+ consecutive missed periods; missed period with symptoms of pregnancy
Clotting	Small clots (smaller than a dime) that are consistent with your flow	Large clots (quarter-sized or larger); clots that are new to your experience; passing clots between periods
Color changes	Shift from bright red to darker blood or vice versa; brown spotting at beginning or end of period	Gray tissue or unusual-colored discharge; foul-smelling discharge with bleeding
Postmenopausal bleeding	N/A - no bleeding after menopause is ever considered "normal adjustment"	ANY vaginal bleeding after confirmed menopause (12 months without periods) requires immediate evaluation

The General Rule of Thumb

A helpful way to think about it: menstrual changes that are mild, temporary, and trending toward improvement are usually part of the normal adjustment process. Changes that are severe, worsening over time, or accompanied by pain or other concerning symptoms should be evaluated.

When in doubt, contact your healthcare provider. It is always better to have a change evaluated and find out it is normal than to ignore something that needs attention. A brief phone call to your provider's office or a message through their patient portal can often determine whether you need an in-person evaluation or can safely continue monitoring.

Tracking Your Cycle: A Practical Guide

Tracking your menstrual cycle while on semaglutide is one of the most valuable things you can do for your own health management. Good tracking data helps you understand patterns, distinguish normal adjustment from concerning changes, communicate effectively with your healthcare provider, and recognize potential pregnancy early.

What to Track

For the most useful tracking while on semaglutide, record the following information:

Every day:

• Whether you are bleeding or spotting
• Flow heaviness on a scale (light, medium, heavy, very heavy)
• Any spotting between periods (note color and amount)
• Pain level (0 to 10 scale)

Cycle-related (when applicable):

• First day of your period (this is "cycle day 1")
• Last day of your period
• Total number of days of bleeding
• Number of products used per day (pads, tampons, cups) and saturation level
• Clot size and frequency
• PMS symptoms and timing
• Any mid-cycle symptoms (ovulation pain, cervical mucus changes)

Semaglutide-specific:

• Injection date and time
• Current dose
• Any dose changes and the date they occurred
• GI side effects (nausea, vomiting) and timing relative to your cycle

Lifestyle factors that affect your cycle:

• Weight (weekly weigh-ins are usually sufficient)
• Significant stress events
• Changes in exercise intensity
• Sleep quality
• Any other medications started or stopped

Recommended Tracking Tools

Several period tracking apps work well for this purpose. When choosing an app, look for one that allows custom notes (so you can log semaglutide-specific data) and that displays cycle length trends over time. Popular options include Clue, Flo, and Stardust, among others. A simple notebook or spreadsheet also works perfectly well.

The most important thing is consistency. Track every day, even on days when nothing notable happens. "Nothing to report" is data too - it helps establish your baseline and identifies patterns.

How to Use Your Tracking Data

After three to four months of tracking, review your data for patterns:

• Is your cycle getting more or less regular? Calculate the number of days from the start of one period to the start of the next for each cycle. Plot these numbers to see the trend. If cycles are gradually becoming more consistent (less variation in length), this is a good sign.
• Do flow changes correlate with dose changes? Check whether heavier or lighter periods occurred around the time of semaglutide dose increases.
• Is breakthrough bleeding decreasing? If you experienced spotting in the first few months, is it becoming less frequent? This suggests your hormones are stabilizing.
• How do your GI side effects interact with PMS? If you notice that nausea or other semaglutide side effects are worse premenstrually, discuss injection timing with your provider.

Bring this tracking data to your healthcare appointments. A few months of cycle data is far more useful to your provider than a verbal recollection of "my periods have been weird." It allows them to assess whether the pattern is consistent with expected semaglutide adjustment or if further evaluation is needed.

Table 5: Cycle Tracking Guide for Women on Semaglutide

Category	What to Record	How to Record It	Why It Matters
Bleeding days	Start date, end date, total days	Mark cycle day 1 clearly; note first and last day of flow	Tracks cycle length and period duration trends
Flow heaviness	Daily rating: light, medium, heavy, very heavy	Also note number and type of products used per day	Identifies if flow is trending heavier or lighter over time
Spotting	Any bleeding between periods	Note color (pink, red, brown), amount, and duration	Helps distinguish normal breakthrough bleeding from concerning symptoms
Pain	Cramps, pelvic pain, back pain	Rate 0-10; note timing in your cycle and what helps	Tracks symptom improvement or identifies concerning patterns
PMS symptoms	Mood changes, bloating, breast tenderness, cravings, headaches	Note which days before period and severity	Shows PMS pattern evolution on treatment
Semaglutide details	Injection date, dose, side effects	Note in the same tracker as your cycle data	Reveals correlations between medication and menstrual changes
Weight	Weekly morning weight (same conditions each time)	Note in tracker; compare to cycle phase	Distinguishes water weight fluctuations from true weight change
Pregnancy tests	Date and result of any pregnancy tests	Note in tracker whenever performed	Provides important safety documentation

When to See Your Gynecologist

Regular gynecological care is important for all women, and it becomes especially important when you are on a medication that can affect your menstrual cycle and fertility. Here is guidance on when to schedule a visit.

Before Starting Semaglutide (Ideally)

If possible, see your gynecologist before starting semaglutide treatment. This visit can establish:

• A baseline understanding of your current menstrual pattern
• Screening for underlying gynecological conditions that could be affected by hormonal changes
• A contraception plan that accounts for semaglutide's effects
• Updated Pap smear and any screening that is due
• Discussion of fertility goals and planning if relevant

During Treatment: Scheduled Check-Ins

Even if everything feels normal, consider scheduling a gynecological check-up at the six-month and twelve-month marks of semaglutide treatment. These visits provide an opportunity to review your tracking data, discuss any changes, adjust contraception if needed, and ensure everything is progressing well.

During Treatment: Urgent Visits

Schedule a prompt gynecological evaluation if you experience any of the following:

• Very heavy bleeding: Soaking a pad or tampon every hour for two or more consecutive hours.
• Prolonged bleeding: A period lasting more than 10 days.
• Amenorrhea: No period for three or more consecutive months (after ruling out pregnancy).
• Severe pain: New, severe, or worsening pelvic pain.
• Intermenstrual bleeding persisting beyond three months: Bleeding between periods that has not resolved after the initial adjustment period.
• Postcoital bleeding: Bleeding after sexual intercourse.
• Suspected pregnancy: Positive pregnancy test or strong suspicion of pregnancy.
• Postmenopausal bleeding: Any vaginal bleeding after confirmed menopause.
• Unusual discharge: Foul-smelling, unusually colored, or otherwise abnormal vaginal discharge with bleeding.
• Anemia symptoms: Extreme fatigue, pallor, shortness of breath, or dizziness that may be related to blood loss.

What to Tell Your Gynecologist

When you visit your gynecologist for menstrual changes on semaglutide, bring the following information:

1. Your cycle tracking data (see the tracking section)
2. The date you started semaglutide
3. Your current dose and dose history
4. How much weight you have lost and over what timeframe
5. Any other medications you are taking
6. Your current contraception method
7. Your fertility goals (if any)
8. Whether you have been diagnosed with PCOS, insulin resistance, or other relevant conditions

This information helps your gynecologist distinguish semaglutide-related adjustments from conditions that need independent evaluation and treatment. Not all gynecologists are familiar with the menstrual effects of GLP-1 medications, so providing comprehensive context helps them give you the best care.

The Emotional Side of Menstrual Changes

We have covered a lot of science and practical guidance in this article, but we would be remiss not to address the emotional dimension of menstrual changes on semaglutide. For many women, these changes carry psychological weight that goes beyond the physical symptoms.

The Anxiety of Unpredictability

For women who have had regular, predictable periods for years or even decades, suddenly having an unpredictable cycle can be genuinely anxiety-inducing. You may find yourself constantly checking for bleeding, worrying about whether to carry menstrual products, or feeling uncertain about planning activities around your period.

This anxiety is completely valid. Your period is something your body has done reliably for years, and when it changes unexpectedly, it raises questions about what else might be changing. It is natural to worry, especially when the medical community has not done a great job of proactively preparing women for these changes.

What helps: Knowledge (which this guide provides), tracking (which gives you data to replace worry), and reassurance from your healthcare provider that the changes are expected and typically temporary.

The Pregnancy Anxiety

For women who do not want to become pregnant, the combination of increased fertility and unpredictable periods can create significant anxiety about contraception. Every late or missed period triggers the question: "Am I pregnant?" This can be especially stressful for women who have been told they have fertility challenges and are now learning that semaglutide may have changed that reality.

What helps: Using a highly reliable non-oral contraceptive method (IUD or implant), keeping pregnancy tests on hand and using them promptly when periods are late, and having a clear plan with your provider for what to do if you become pregnant.

The Identity Dimension

Your menstrual cycle is part of your body's identity. When it changes, especially in the context of other body changes from weight loss, it can feel like your body is transforming in ways that feel unfamiliar. Some women describe feeling disconnected from their bodies during the adjustment period, particularly if they experience significant changes in appetite, body shape, energy levels, and menstrual patterns all at the same time.

What helps: Patience with yourself. Acknowledging that your body is going through a significant transition. Connecting with other women who are going through similar experiences (online communities and support groups can be valuable). Talking to a therapist if the emotional impact is significant.

The Relief of Improved Periods

On the positive side, many women experience genuine emotional relief when their periods improve on semaglutide. Women who spent years dealing with heavy, painful, or unpredictable periods - particularly those with PCOS - often describe feeling liberated when their cycles become regular and manageable. Getting a predictable period after years of chaos can be emotionally significant in ways that are hard to overstate.

Some women have told their healthcare providers that the improvement in their menstrual cycle was one of the most meaningful benefits of semaglutide treatment - even more meaningful to them than the weight loss itself. For women with PCOS who had been told they might not be able to conceive, seeing regular ovulatory cycles return can be profoundly hopeful.

The Fertility Ambivalence

For women who are ambivalent about pregnancy - perhaps not actively trying to conceive but not entirely opposed either - the increased fertility from semaglutide introduces a complex emotional dynamic. It may force decisions about contraception and family planning that had previously been deferred. This is a conversation worth having with both your partner and your healthcare provider, ideally before starting treatment.

Seeking Emotional Support

If the emotional impact of menstrual changes on semaglutide is affecting your quality of life, well-being, or the ability to continue treatment, please consider:

• Talking to your prescribing provider about your concerns. They may be able to adjust your treatment approach or provide reassurance.
• Asking for a referral to a therapist or counselor, particularly one experienced with body image and hormonal health.
• Connecting with support communities where other women on GLP-1 medications share their experiences.
• Journaling about your feelings alongside your cycle tracking. Sometimes putting emotions into words helps process them.
• Being honest with your partner, family, or close friends about what you are experiencing. Social support matters.

You are navigating a significant physiological transition. It is okay for it to feel hard sometimes. It is also okay to feel relieved, hopeful, or even joyful about the positive changes. Whatever you are feeling is valid.

How Your Menstrual Cycle Affects the Scale

If you are tracking your weight while on semaglutide (and most women are), how your menstrual cycle can temporarily distort the numbers on the scale. Many women become frustrated or discouraged when they see the scale spike during certain phases of their cycle, and understanding why this happens can prevent unnecessary stress.

The Menstrual Cycle and Water Retention

Throughout your menstrual cycle, fluctuating levels of estrogen and progesterone affect how much water your body retains. Here is what typically happens:

Follicular phase (days 1 through approximately 14): This is the phase from the start of your period through ovulation. Estrogen gradually rises during this phase. Water retention is generally at its lowest, and many women see their lowest scale weight during the first week of their cycle (during their period).

Ovulation (approximately day 14): Estrogen peaks just before ovulation. Some women notice a slight increase in water retention around this time, but it is usually minimal.

Luteal phase (approximately days 15 through 28): After ovulation, progesterone rises sharply. Progesterone promotes water retention and can cause bloating, breast tenderness, and a general feeling of "puffiness." This is when most women see their highest scale weight - typically 1 to 5 pounds above their lowest weight, though some women experience fluctuations of up to 7 to 8 pounds.

Premenstrual days (2 to 5 days before your period): Water retention is typically at its peak. Many women report feeling their most bloated and seeing their highest scale numbers in the 2 to 3 days before their period starts.

Menstruation: As your period begins, progesterone drops and the body begins to release retained water. Many women notice that they urinate more frequently in the first day or two of their period as this excess water is flushed out. The scale may drop several pounds over just a few days.

How This Interacts with Semaglutide Weight Loss

When you are losing weight on semaglutide, the cyclical water weight fluctuations can mask your actual fat loss progress. Here is a common frustrating scenario:

You have been losing weight steadily for several weeks. Then, in the week before your period, the scale suddenly goes up 3 pounds. You feel discouraged and wonder if the medication has stopped working. Then your period comes, and within a few days, the scale drops 5 pounds. You did not actually gain weight during the luteal phase - you gained water. And the "big drop" after your period is a combination of losing that water weight plus the actual fat loss that was happening all along but was hidden by the water retention.

Practical Tips for Weighing Yourself on Semaglutide

• Weigh weekly, not daily. Pick one day of the week and weigh yourself at the same time (ideally morning, after using the bathroom, before eating or drinking). This reduces the impact of day-to-day water weight fluctuations.
• Compare the same phase of your cycle. The most meaningful weight comparison is between the same phase of your cycle each month. For example, compare your weight on day 5 of this cycle to day 5 of last cycle.
• Track the trend, not individual data points. Whether you use a weight tracking app or a simple spreadsheet, look at the overall trend line over weeks and months rather than fixating on any single weigh-in.
• Expect a "stall" before your period. Weight loss often appears to plateau or reverse in the luteal phase. This is water, not fat. The weight loss has not actually stopped.
• Consider your lowest weight each cycle as your "true" weight. Some providers recommend using your lowest weight during each menstrual cycle (usually during your period or the few days after) as the most accurate measure of your actual body composition progress.
• Use body measurements as a complement. Waist circumference, hip measurements, and how your clothing fits are less affected by water retention and can provide a more consistent picture of your progress.

Dose Titration and Period Effects

Semaglutide treatment involves a gradual dose escalation (titration) schedule. For weight management, the standard titration goes from 0.25 mg weekly to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, with each step lasting approximately four weeks. Many women notice that their menstrual cycle is particularly sensitive to dose changes.

Why Dose Changes Affect Your Period

Each increase in semaglutide dose amplifies the medication's effects. Appetite suppression increases, which can lead to a further reduction in caloric intake and acceleration of weight loss. Gastric emptying is further slowed. The metabolic and hormonal effects of the medication intensify.

These amplified effects create a mini-adjustment period with each dose increase, and for many women, that includes temporary menstrual disruption. The most commonly reported pattern is spotting or mild breakthrough bleeding one to two weeks after a dose increase, or a period that arrives a few days early or late in the cycle following a dose increase.

Which Dose Jumps Are Most Likely to Affect Your Period

Based on clinical observation and patient reports, the dose increases most likely to cause menstrual changes are:

1. 0.25 mg to 0.5 mg: This is when many women first notice appetite suppression and more rapid weight loss, making it a common trigger for initial menstrual changes.
2. 0.5 mg to 1.0 mg: This is often the dose where side effects (including menstrual changes) peak, as 1.0 mg represents a significant increase in GLP-1 receptor activation.
3. 1.0 mg to 1.7 mg: Some women experience additional disruption at this step, though many find that their body has largely adapted by this point.
4. 1.7 mg to 2.4 mg: The final dose increase typically causes fewer menstrual changes because the body has been adjusting gradually and the incremental increase in effect is smaller relative to what the body is already adapted to.

Managing Period Changes During Dose Titration

• Note dose changes in your cycle tracker. Mark the date and new dose so you can see correlations between dose changes and menstrual changes.
• Be prepared for spotting. Keep pantyliners on hand for the one to two weeks following a dose increase.
• Discuss timing with your provider. If your menstrual changes are particularly bothersome with dose increases, your provider may recommend extending the duration at each dose level (for example, staying at 0.5 mg for six to eight weeks instead of four before increasing to 1.0 mg). This allows your hormones more time to adjust at each step.
• Consider injection timing. Some women find that scheduling their semaglutide injection during the first week of their cycle (just after their period ends) rather than during the premenstrual or menstrual phase helps minimize the overlap of medication side effects and menstrual symptoms.

Menstrual Effects of Other GLP-1 Medications

While this guide focuses on semaglutide, many of the same principles apply to other GLP-1 receptor agonists and related medications. Here is how the major alternatives compare:

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide is a dual GIP/GLP-1 receptor agonist that typically produces greater weight loss than semaglutide. In clinical trials, tirzepatide at its highest dose (15 mg) produced average weight loss of 22.5 percent of body weight, compared to approximately 15 percent for semaglutide 2.4 mg.

Because the mechanisms driving menstrual changes are primarily related to weight loss and improved insulin sensitivity rather than the specific medication, tirzepatide's menstrual effects are similar to semaglutide's but can be more pronounced because of the greater and faster weight loss. Women on tirzepatide should expect:

• The same types of menstrual changes (irregular timing, flow changes, breakthrough bleeding, PMS changes)
• Potentially more dramatic changes due to faster and greater weight loss
• The same timeline pattern (adjustment, transition, stabilization) but possibly with a longer adjustment phase
• The same fertility and contraception considerations

Liraglutide (Saxenda, Victoza)

Liraglutide is an older GLP-1 receptor agonist that requires daily injection and produces less weight loss than semaglutide (approximately 5 to 8 percent of body weight). Because the weight loss is more modest and more gradual, menstrual changes on liraglutide tend to be less dramatic. However, the same mechanisms are at work, and women on liraglutide should still track their cycles and use reliable contraception.

Oral Semaglutide (Rybelsus)

Oral semaglutide (Rybelsus) is currently approved for type 2 diabetes at doses up to 14 mg, with higher doses being studied for weight management. The menstrual effects are the same as injectable semaglutide because the active ingredient is identical. The oral formulation does not introduce any unique menstrual considerations, though the oral contraceptive interaction may be more relevant since both the medication and the birth control pill are being absorbed through the GI tract.

Compounded Semaglutide

Compounded semaglutide contains the same active ingredient as brand-name Ozempic and Wegovy. The menstrual effects discussed throughout this guide apply equally to compounded formulations. There are no menstrual-specific differences between brand-name and compounded semaglutide when the active ingredient and dose are equivalent.

Frequently Asked Questions

Below are detailed answers to the most common questions women ask about semaglutide and menstrual changes. For quick answers, refer to the FAQ schema at the top of this page. For deeper understanding, read the expanded answers below along with the relevant sections of this guide.

1. Does semaglutide affect your period?

Yes. Many women report menstrual changes while taking semaglutide, including irregular cycle timing, changes in flow heaviness (heavier or lighter), breakthrough bleeding or spotting between periods, changes in PMS symptoms, and shifts in cycle length. These changes are driven by multiple mechanisms: decreased estrogen from fat tissue loss, improved insulin sensitivity altering the hormonal environment, potential restoration of ovulation in previously anovulatory women, effects of caloric deficit on the hypothalamic-pituitary-ovarian axis, and reduced systemic inflammation. For most women, these changes are temporary and resolve within 6 to 12 months of starting treatment. See the science section for a detailed explanation of each mechanism.

2. Why does weight loss cause period changes?

Fat tissue is an active endocrine organ that produces estrogen through an enzyme called aromatase. When you lose a significant amount of body fat on semaglutide, your body's estrogen production from this source decreases. Since estrogen is a primary driver of the menstrual cycle - it stimulates endometrial growth, triggers ovulation, and orchestrates cycle timing - changes in estrogen levels naturally affect your period. The more weight you lose and the faster you lose it, the more pronounced these changes tend to be. This is not unique to semaglutide; equivalent weight loss from any method would produce similar menstrual effects. See Estrogen and Fat Tissue for the full explanation.

3. Can Ozempic cause heavy periods?

Yes, heavier menstrual bleeding is reported by some women, especially during the first 3 to 6 months of treatment. This can result from estrogen withdrawal triggering heavier shedding of a previously thicker endometrial lining, the resumption of ovulatory cycles producing progesterone-withdrawal bleeds that feel different from anovulatory bleeding, and hormonal fluctuations during the transition period causing irregular endometrial buildup. While some increase in flow is normal during adjustment, very heavy bleeding (soaking a pad every hour, passing large clots, periods lasting over 10 days) should be evaluated by your healthcare provider. See Heavy Periods on Semaglutide for full details and management strategies.

4. Can semaglutide make your period lighter?

Yes, and lighter periods are actually more common than heavier periods once you are past the initial adjustment phase. As estrogen levels decrease with fat loss, the endometrial lining builds up less thickly each cycle, resulting in less tissue to shed and lighter flow. This is generally considered a positive change and is not concerning unless periods become extremely light or stop entirely for three or more months. Women who had heavy periods related to higher body weight or PCOS may notice particularly significant lightening. See Light Periods and Reduced Flow.

5. Does semaglutide cause breakthrough bleeding?

Breakthrough bleeding (spotting between periods) is one of the most commonly reported menstrual changes during the first one to three months of semaglutide treatment. It is typically light (pink to brown spotting), lasts one to three days, and often occurs around the time of dose increases or mid-cycle near ovulation. The cause is usually fluctuating estrogen levels disrupting the stability of the endometrial lining. Breakthrough bleeding that persists beyond three months, is heavy, or occurs after menopause should be evaluated. See Breakthrough Bleeding and Spotting.

6. Will my period go back to normal on semaglutide?

For the majority of women, yes. Menstrual cycles typically stabilize within 6 to 12 months of starting semaglutide as the body adjusts to new hormone levels, weight stabilizes, and the hormonal environment reaches a new equilibrium. Many women report that their cycles become more regular than they were before treatment, particularly if they had irregular periods related to excess weight, insulin resistance, or PCOS. The "new normal" may be slightly different from your pre-treatment pattern (often lighter periods, slightly different cycle length), but it is typically consistent and predictable. See the Timeline section for month-by-month expectations.

7. Can semaglutide affect birth control pills?

Yes. Semaglutide slows gastric emptying, which means oral medications (including birth control pills) may take longer to be absorbed. While pharmacokinetic studies suggest the total amount of contraceptive hormone absorbed is generally not dramatically reduced, the timing and peak blood levels can be altered. Additionally, if semaglutide causes vomiting within a few hours of taking your birth control pill, the hormones may not be fully absorbed. Many healthcare providers recommend using a backup method (condoms) during the first three months of semaglutide treatment, or switching to a non-oral contraceptive (IUD, implant, patch, or ring) that is not affected by gastric emptying. See the Contraception section for a complete comparison of methods.

8. Can you get pregnant on semaglutide?

Yes, and this is critically important. Semaglutide can increase fertility by improving insulin sensitivity, promoting weight loss, and restoring ovulation in women who were not ovulating regularly. The phenomenon of "Ozempic babies" - unintended pregnancies in women on GLP-1 medications - has been widely reported. You must use reliable contraception while taking semaglutide, even if you previously had irregular or absent periods. Semaglutide is classified as a pregnancy risk medication and must be discontinued at least two months before a planned pregnancy. If you miss a period, take a pregnancy test before assuming it is a medication side effect. See Restored Ovulation and Surprise Fertility.

9. How does semaglutide affect periods in women with PCOS?

Women with PCOS often experience the most dramatic and positive menstrual changes on semaglutide. By improving insulin sensitivity and promoting weight loss, semaglutide addresses the two primary drivers of PCOS-related menstrual irregularity. Many women with PCOS report getting regular periods for the first time in years, often within three to six months of starting treatment. The cascade of improvements includes reduced ovarian androgen production, increased SHBG, improved follicle development, and restored ovulation. However, restored ovulation also means increased fertility, making reliable contraception especially important for PCOS patients. See the dedicated PCOS section for comprehensive details.

10. Does semaglutide affect periods during perimenopause?

Semaglutide adds another layer of hormonal change to the already variable space of perimenopause. Both perimenopause and semaglutide-related weight loss can cause irregular periods, changes in flow, and unpredictable cycle timing, making it difficult to determine which changes are from which cause. Unique considerations include the potential for worsened hot flashes (from compounded estrogen reduction), bone health concerns, and the need for continued contraception until menopause is confirmed. Work closely with your provider to monitor both processes. See the Perimenopause section.

11. Should I stop semaglutide if my period changes?

In most cases, no. Menstrual changes on semaglutide are usually temporary and resolve as your body adjusts to new hormone levels. Stopping the medication solely because of period changes would mean giving up the metabolic and weight loss benefits of treatment for a side effect that is typically self-limiting. However, certain changes do warrant medical evaluation and could potentially require treatment modification. Contact your provider if you experience very heavy bleeding, periods lasting over 10 days, amenorrhea for three or more months, or severe pelvic pain. Your provider will help determine whether the changes are a normal part of adjustment or require intervention.

12. Does semaglutide change PMS symptoms?

Many women report changes in PMS on semaglutide, and the changes are often positive. Blood sugar stabilization can reduce mood swings, irritability, and cravings. Reduced inflammation can decrease cramping and bloating. Improved serotonin signaling may improve premenstrual mood symptoms. However, some women experience temporary worsening of bloating (from delayed gastric emptying) and nausea (from overlap of semaglutide GI effects and premenstrual symptoms) during the first few months. Most women report that PMS improves or stabilizes within three to six months. See PMS Changes for management tips.

13. Can semaglutide cause amenorrhea (no period)?

Temporary amenorrhea can occur, particularly during periods of rapid weight loss or significant caloric restriction. However, amenorrhea lasting three or more months should always be evaluated because it could indicate pregnancy (especially given semaglutide's fertility-enhancing effects), hypothalamic amenorrhea from inadequate nutrition, or an unrelated medical condition. The first step is always a pregnancy test. If negative, blood work to assess thyroid function, prolactin, FSH, LH, and estradiol levels can help identify the cause. See the Amenorrhea section for a complete evaluation guide.

14. How should I track my period on semaglutide?

Track daily: whether you are bleeding or spotting, flow heaviness, pain level, and any PMS symptoms. Also track semaglutide-specific data: injection dates, current dose, dose changes, and GI side effects. Record weekly weight and any significant lifestyle changes (stress, exercise, diet). Use a period tracking app that allows custom notes or a simple journal. The goal is to provide your healthcare provider with clear data that helps them distinguish normal adjustment from changes that need evaluation. See the Tracking section for a detailed guide and table.

15. Does the dosage of semaglutide affect periods?

Yes. Dose increases during titration can trigger temporary menstrual irregularity because each step up amplifies the medication's effects on appetite, weight loss, and metabolism. Many women notice spotting or timing shifts within one to two weeks of a dose increase, with the moves from 0.25 to 0.5 mg and from 0.5 to 1.0 mg being the most common triggers. These changes typically resolve within one to two cycles at the new dose. Noting dose changes in your cycle tracker helps identify these patterns. See Dose Titration and Period Effects.

16. Is it normal to have two periods in one month on semaglutide?

Having two periods in one month (polymenorrhea) can occur during the first few months of treatment due to hormonal fluctuations shortening your cycle or causing breakthrough bleeding that mimics a second period. A single occurrence is usually not concerning. However, recurrent episodes should be evaluated to rule out other causes such as uterine polyps, fibroids, thyroid dysfunction, or cervical conditions. If this happens once during the adjustment period, note it in your tracker and monitor. If it becomes a pattern, see your provider.

17. When should I see a gynecologist about period changes on semaglutide?

See your gynecologist promptly for: very heavy bleeding (soaking a pad every hour), periods lasting more than 10 days, no period for three or more consecutive months, severe or worsening pelvic pain, bleeding between periods persisting beyond three months, any postcoital bleeding, suspected pregnancy, or any bleeding after confirmed menopause. Ideally, also have a baseline gynecological visit before starting semaglutide and check-ins at the six-month and twelve-month marks. See When to See Your Gynecologist.

18. Do menstrual changes on semaglutide affect weight loss?

Menstrual cycle phases do not affect actual fat loss from semaglutide, but they significantly affect the number on the scale due to water retention. Most women retain 1 to 5 pounds of water in the luteal phase (before their period) and lose it during or after menstruation. This can create the illusion of weight loss "stalls" that are actually just water masking ongoing fat loss. Weigh yourself weekly at the same time, compare the same cycle phase month to month, and look at the overall trend rather than individual data points. See How Your Menstrual Cycle Affects the Scale.

19. Can semaglutide help with endometriosis symptoms?

While semaglutide is not a treatment for endometriosis, some women with the condition report improvements in inflammatory symptoms. GLP-1 medications have documented anti-inflammatory properties, and weight loss reduces systemic inflammation and peripheral estrogen production. Since endometriosis is an estrogen-dependent, inflammatory condition, these effects could theoretically provide some benefit. However, dedicated research on this specific interaction is limited, and semaglutide should not be used or relied upon as an endometriosis treatment. Discuss your endometriosis management separately with your gynecologist.

20. Does semaglutide interact with hormone replacement therapy (HRT)?

There are no known direct drug interactions between semaglutide and HRT. However, two practical considerations exist. First, if you take oral HRT (pills), the delayed gastric emptying from semaglutide may slightly affect absorption timing. Transdermal HRT (patches, gels, sprays) bypasses the GI tract and is not affected. Second, weight loss may change how your body metabolizes and responds to HRT, potentially requiring dose adjustment. Discuss the timing of your HRT relative to meals and semaglutide injections with your provider.

21. Are menstrual changes different on tirzepatide versus semaglutide?

The types of menstrual changes are the same because both medications work through similar mechanisms (weight loss, improved insulin sensitivity). However, tirzepatide typically produces faster and greater weight loss due to its dual GIP/GLP-1 receptor activation, which can mean more pronounced menstrual disruption during the adjustment period. The same principles, timelines, and management strategies apply. The contraception and fertility considerations are equally important for both medications.

22. Can semaglutide affect fertility treatments like IVF?

Semaglutide must be discontinued before fertility treatments including IVF. Current guidelines recommend stopping the medication at least two months before attempting conception through any method. However, weight loss achieved through semaglutide treatment before beginning IVF may actually improve outcomes, since obesity is associated with lower IVF success rates. Many reproductive endocrinologists are now recommending a period of semaglutide-assisted weight loss before fertility treatment in appropriate patients. Coordinate timing between your prescribing provider and reproductive endocrinologist.

Nutrition, Semaglutide, and Menstrual Health

One of the most overlooked aspects of menstrual health on semaglutide is nutrition. The appetite suppression caused by GLP-1 medications is exactly what makes them effective for weight loss, but it can also lead to inadequate nutrition that compounds the hormonal disruption already occurring from weight loss. Understanding the relationship between what you eat and how your menstrual cycle functions can help you handle this balance.

Why Adequate Nutrition Matters for Your Cycle

Your menstrual cycle is, from an evolutionary perspective, a luxury function. When your body perceives that resources are scarce, it prioritizes survival over reproduction. This means that severe caloric restriction sends signals to the hypothalamus to suppress the reproductive axis. The result is disrupted or absent ovulation, irregular periods, and eventually amenorrhea.

Many women on semaglutide eat significantly less than they realize. The appetite suppression can be so effective that some women consume fewer than 800 to 1,000 calories daily without feeling hungry. While this produces rapid weight loss, it can also push the body into an energy-deficit state that disrupts menstrual function beyond what weight loss alone would cause.

The distinction is important. Menstrual changes from gradual, moderate weight loss (driven by reduced peripheral estrogen) are a normal and expected physiological adjustment. Menstrual disruption from severe caloric restriction (driven by hypothalamic suppression) is a signal that your body is not getting enough fuel, and it warrants intervention.

Key Nutrients for Menstrual Health on Semaglutide

Protein (60 to 100 grams daily): Protein is essential for hormone production, including the reproductive hormones that drive your menstrual cycle. It also supports muscle preservation during weight loss, which is critical for metabolic health. When appetite is low on semaglutide, prioritize protein at every meal. Lean meats, fish, eggs, Greek yogurt, cottage cheese, and legumes are excellent sources. Protein shakes can help on days when solid food is unappealing.

Iron (18 mg daily for premenopausal women): Iron is lost through menstrual bleeding, and if your periods are heavier during the semaglutide adjustment phase, your iron needs may increase. Iron deficiency is the most common nutritional deficiency worldwide in women of reproductive age, and the combination of reduced food intake and potentially heavier periods can accelerate iron depletion. Good sources include red meat, dark leafy greens, fortified cereals, and legumes. Consider a supplement if blood work shows low ferritin levels.

Healthy fats (at least 40 to 60 grams daily): Dietary fat is the building block for all steroid hormones, including estrogen and progesterone. Very low-fat diets can contribute to hormonal disruption and menstrual irregularity. Include sources like avocado, olive oil, nuts, seeds, fatty fish, and eggs. Women who follow extremely low-fat diets while on semaglutide may experience more menstrual disruption than those who maintain adequate fat intake.

Complex carbohydrates: While reducing refined carbohydrates is generally beneficial, severely restricting all carbohydrates can affect thyroid function and the HPO axis. Include whole grains, sweet potatoes, fruits, and legumes in your diet. Carbohydrates also support serotonin production, which can help with premenstrual mood symptoms.

Calcium (1,000 to 1,200 mg daily): Calcium supports bone health (important as estrogen levels change) and has evidence for reducing PMS symptoms. Dairy products, fortified plant milks, dark leafy greens, and sardines with bones are good sources.

Magnesium (400 mg daily): Magnesium plays a role in hundreds of enzymatic reactions including hormone metabolism. It can help reduce menstrual cramps, improve sleep, and support mood regulation. Many women are mildly deficient in magnesium even before starting semaglutide, and reduced food intake can worsen this. Magnesium glycinate is the best-tolerated supplemental form.

Vitamin D (1,000 to 2,000 IU daily): Vitamin D receptors are found in reproductive tissues including the ovaries and uterus. Deficiency is common and is associated with menstrual irregularity and worsened PCOS symptoms. Supplementation is recommended for most adults, regardless of semaglutide use.

Zinc (8 to 11 mg daily): Zinc supports healthy ovulation and progesterone production. It is found in meat, shellfish, legumes, nuts, and seeds. As with other micronutrients, reduced food intake on semaglutide may make it harder to meet zinc requirements through diet alone.

Practical Nutrition Tips for Menstrual Health on Semaglutide

• Aim for at least 1,200 calories daily. Even on days when appetite is very low, try to consume enough calories to support basic physiological function. If you are consistently eating less than 1,200 calories, discuss this with your provider.
• Protein first at every meal. When you have limited appetite, make every bite count by prioritizing protein-rich foods before anything else.
• Consider a prenatal or women's multivitamin. A comprehensive multivitamin can help fill nutritional gaps created by reduced food intake. Prenatal vitamins are particularly good choices because they contain adequate iron, folate, and other nutrients important for reproductive health.
• Eat small, frequent meals. Rather than trying to eat three large meals (which may feel impossible on semaglutide), aim for five to six smaller meals or snacks throughout the day.
• Do not intentionally restrict calories beyond what the medication naturally produces. Semaglutide reduces appetite; you do not need to diet on top of it. Eating when hungry and stopping when full is sufficient. Adding intentional restriction can push your body into a state of energy deficit that harms menstrual and overall health.
• Track nutrition periodically. Use a food tracking app for three to five days every few weeks to check whether you are meeting basic caloric and protein requirements. Many women are surprised to find they are eating significantly less than they thought.

Talking to Your Provider About Period Changes

Having productive conversations with your healthcare provider about menstrual changes on semaglutide can be challenging. Some providers are not yet fully aware of the menstrual effects of GLP-1 medications, and the topic of period changes can feel uncomfortable to bring up, particularly if your semaglutide prescriber is not a gynecologist.

Preparing for the Conversation

Before your appointment, organize the following information to share:

1. Your menstrual history before semaglutide: How long were your cycles? How heavy were your periods? Did you have regular or irregular cycles? Any previous gynecological conditions?
2. Your current cycle data: Bring your tracking records showing cycle dates, flow changes, spotting episodes, and symptoms since starting semaglutide.
3. Your semaglutide timeline: When did you start? What doses have you been on? When did each dose increase occur? How much weight have you lost?
4. Your specific concerns: What worries you most? Is it the unpredictability? The heaviness? The possibility of pregnancy? Being specific helps your provider address your actual concerns rather than providing generic reassurance.
5. Your contraception status: What are you currently using? Is it working well? Do you have concerns about effectiveness?
6. Your fertility goals: Are you trying to avoid pregnancy? Trying to conceive in the future? Unsure? This context shapes your provider's recommendations.

Questions to Ask Your Provider

Consider asking some or all of the following questions:

• "Are the menstrual changes I am experiencing consistent with what you would expect from semaglutide-related weight loss?"
• "Should I have any testing done to rule out other causes of my menstrual changes?"
• "Is my current contraception method reliable enough given the potential interaction with semaglutide?"
• "How much weight loss would you expect before my cycle stabilizes?"
• "Should I see a gynecologist about these changes, or is monitoring with you sufficient?"
• "Are there any nutritional adjustments I should make to support my menstrual health?"
• "If I want to become pregnant in the future, what is the recommended timeline for stopping semaglutide?"
• "Should I take an iron supplement given the changes in my bleeding pattern?"

When Your Provider and Your Gynecologist Should Coordinate

In an ideal scenario, your semaglutide-prescribing provider and your gynecologist communicate about your care. This is particularly important if:

• You have PCOS and are experiencing significant menstrual changes
• You are in perimenopause and taking or considering HRT
• You have a history of endometriosis, fibroids, or other gynecological conditions
• You are experiencing amenorrhea that requires evaluation
• You have fertility goals that need to be coordinated with semaglutide treatment
• You need a contraception change and want both providers' input

If your providers are not in the same health system, you can help with communication by sharing records between offices, asking for summary notes from each visit, and giving permission for the providers to contact each other. Being your own healthcare advocate in this way ensures that both aspects of your care - metabolic health and reproductive health - are being managed in coordination.

Communicating with Your Partner About Menstrual Changes

If you have a partner, the menstrual changes you experience on semaglutide affect them too, especially when it comes to contraception decisions, family planning, and understanding what you are going through physically and emotionally. Having open conversations can strengthen your relationship and ensure you are both on the same page.

What Your Partner Should Know

• Contraception is a shared responsibility. The increased fertility risk on semaglutide is not just your concern. If you are using condoms as a backup method, both partners need to be committed to consistent use. If you are considering switching to a long-acting method like an IUD, your partner should understand why.
• Unpredictable periods affect daily life. Unexpected bleeding can mean canceled plans, discomfort, or anxiety. Your partner's understanding and flexibility during the adjustment period matters.
• PMS and mood changes may shift. If your PMS pattern changes - whether symptoms improve or temporarily worsen - your partner benefits from knowing that this is a temporary adjustment related to your treatment.
• Pregnancy concerns are real. If you are not planning a pregnancy, the anxiety of a late period on semaglutide can be stressful. Having a partner who understands why you might want to take a pregnancy test after a late period (even if you are on contraception) is supportive.
• Family planning may need to be discussed. If semaglutide is restoring your fertility, it may be time to have (or revisit) conversations about whether and when you want to have children.

For Partners Reading This

If your partner is on semaglutide and experiencing menstrual changes, here are some ways to be supportive:

• Ask how they are feeling and listen without trying to fix things. Sometimes acknowledgment is enough.
• Be flexible about plans if unexpected bleeding or discomfort disrupts the schedule.
• Be willing to use backup contraception (condoms) during the adjustment period if asked.
• Participate in contraception decisions as a team rather than leaving all the burden of prevention on your partner.
• Understand that the emotional dimension of body changes, cycle changes, and treatment adjustment is real and valid.
• Offer to go along to medical appointments if your partner wants support.

These are deeply personal aspects of health and relationship dynamics. There is no single right approach. What matters is that the conversation happens and that both partners feel heard and supported.

Exercise, Semaglutide, and Your Cycle

Exercise is strongly recommended during semaglutide treatment for muscle preservation, metabolic health, and overall well-being. But the type, timing, and intensity of exercise can interact with your menstrual cycle in ways worth understanding.

How Exercise Affects Your Period on Semaglutide

Moderate exercise supports menstrual regularity. Regular, moderate-intensity exercise (150 minutes per week as recommended by the American College of Sports Medicine) tends to support a healthy menstrual cycle. It improves insulin sensitivity (complementing semaglutide's effects), reduces inflammation, supports mood, and helps manage stress - all of which contribute to hormonal balance.

Excessive exercise can disrupt your cycle. Very intense or prolonged exercise, particularly if combined with the caloric deficit already created by semaglutide, can push the body into a state of energy deficit that triggers hypothalamic suppression of the reproductive axis. This is the same mechanism seen in the female athlete triad (now part of the broader concept of Relative Energy Deficiency in Sport, or RED-S). If your exercise creates an energy expenditure that, combined with your reduced intake on semaglutide, leaves your body in a severe deficit, your periods may become irregular or stop.

The key is balance. Exercise should complement semaglutide treatment, not create additional physiological stress. If you are exercising intensely and your periods become irregular or stop, consider reducing exercise intensity or increasing caloric intake before assuming the change is solely from semaglutide.

Exercise Recommendations by Cycle Phase

While you do not need to dramatically alter your exercise based on your cycle phase, understanding how your body may feel during different phases can help you optimize your workouts:

• Menstruation (days 1 to 5): Energy may be lower, especially if you are also dealing with semaglutide side effects. Lighter exercise like walking, yoga, or gentle swimming is appropriate. Do not force intense workouts if you feel unwell.
• Follicular phase (days 6 to 14): Many women feel their strongest and most energetic during this phase as estrogen rises. This is often the best time for higher-intensity workouts and strength training.
• Ovulation (approximately day 14): Energy is typically high. Some women are more injury-prone around ovulation due to estrogen's effect on ligament laxity, so pay attention to form during strength training.
• Luteal phase (days 15 to 28): Progesterone rises, which can cause fatigue, bloating, and reduced exercise tolerance. This is a good phase for moderate-intensity exercise. Be aware that semaglutide-related nausea may be amplified during this phase for some women.

Strength Training Is Especially Important

Resistance training (strength training) is particularly important for women on semaglutide because it helps preserve lean muscle mass during weight loss. Muscle loss during rapid weight loss can affect metabolic rate, bone density, and physical function. Aim for two to three strength training sessions per week, focusing on compound movements (squats, deadlifts, presses, rows) that work multiple muscle groups.

Strength training also supports menstrual health indirectly by improving insulin sensitivity, supporting bone density (important as estrogen changes), and promoting body composition changes that contribute to long-term hormonal balance.

References and Further Reading

This guide draws on a combination of clinical trial data, pharmacological research, endocrinology literature, gynecological guidelines, and clinical observations. Below are key references and resources for women who want to explore specific topics in more depth.

Clinical Trial Data

• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002.
• Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet. 2021;397(10278):971-984.
• Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413.
• Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414-1425.
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
• Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine. 2023;389(24):2221-2232.

Weight Loss and Menstrual Function

• Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217.
• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology. 2018;14(5):270-284.
• Silvestris E, et al. Obesity as disruptor of the female fertility. Reproductive Biology and Endocrinology. 2018;16(1):22.
• Metwally M, et al. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertility and Sterility. 2008;90(3):714-726.
• Pasquali R, et al. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Hormone Research. 1993;39(5-6):179-187.

Hormonal Mechanisms

• Nelson LR, Bulun SE. Estrogen production and action. Journal of the American Academy of Dermatology. 2001;45(3 Suppl):S116-124.
• Azziz R, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility. 2009;91(2):456-488.
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews. 2012;33(6):981-1030.
• Berga SL, Loucks TL. Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Annals of the New York Academy of Sciences. 2006;1092:114-129.

GLP-1 Pharmacology and Reproductive Effects

• Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism. 2018;27(4):740-756.
• Novo Nordisk. Wegovy (semaglutide) Prescribing Information. Revised 2024.
• Novo Nordisk. Ozempic (semaglutide) Prescribing Information. Revised 2024.
• Eli Lilly. Zepbound (tirzepatide) Prescribing Information. Revised 2024.

Contraception and Drug Interactions

• Curtis KM, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recommendations and Reports. 2016;65(3):1-103.
• Hjerpsted JB, et al. Semaglutide does not compromise the pharmacokinetics of oral contraceptives. Diabetes. 2018;67(Supplement 1):A306.
• American College of Obstetricians and Gynecologists. Obesity and Reproductive Health. Practice Bulletin No. 230. Obstetrics & Gynecology. 2021.

Related Articles